Vinay K Rathi
Overview
Explore the profile of Vinay K Rathi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller L, Adunka O, Rathi V
JAMA Otolaryngol Head Neck Surg
. 2025 Mar;
PMID: 40048175
No abstract available.
2.
Bhat A, Schlosser R, Soler Z, Rathi V
Laryngoscope
. 2025 Mar;
PMID: 40026190
The Food and Drug Administration (FDA) recently approved several novel therapies to treat chronic rhinosinusitis with nasal polyps (CRSwNP), though high prices may burden patients and payers. CRSwNP-specific spending varied...
3.
Walia A, Xiao R, Hao D, Rathi V, Sethi R, Gray S
OTO Open
. 2025 Feb;
9(1):e70086.
PMID: 39896852
While outpatient otolaryngology procedures have been increasingly performed at ambulatory surgery centers (ASCs), the cost differences compared to hospital outpatient departments (HOPDs) remain unclear. Utilizing newly available data collected from...
4.
Miller L, Miller A, Rocco J, Rathi V
Otolaryngol Head Neck Surg
. 2025 Jan;
PMID: 39865452
The Centers for Medicare & Medicaid Services (CMS) recently increased payment for evaluation and management (E/M) visits, but did not apply these updates to post-operative global period visits. We investigated...
5.
Workman A, Lerner D, Rathi V, Douglas J, Kohanski M, Adappa N, et al.
Int Forum Allergy Rhinol
. 2025 Jan;
PMID: 39811965
In patients with severe olfactory and gustatory dysfunction, olfactory cleft opacification improves with expanded intranasal steroid treatment (EDS-FLU) relative to placebo. This is directly associated with objective and patient-reported taste/smell...
6.
Chapurin N, Soler Z, Khan S, Mulligan J, Ramakrishnan V, Mace J, et al.
Int Forum Allergy Rhinol
. 2024 Dec;
PMID: 39740083
Background: Quantitative mucus cytokine analysis to examine the sinonasal microenvironment may bridge the gap between patient-reported outcome measures (PROMs) and empirical measures of inflammation in patients with chronic rhinosinusitis (CRS)....
7.
Hao D, Rathi V, Ross J, Sethi R, Xiao R
Am J Manag Care
. 2024 Nov;
30(11):545-546.
PMID: 39546756
Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.
8.
Moneer O, Johnston J, Rathi V, Ross J, Dhruva S
JAMA Health Forum
. 2024 Nov;
5(11):e244016.
PMID: 39546305
Importance: Medicare transitional pass-through payments (TPTPs) provide supplemental reimbursement that is intended to facilitate adoption of new devices in the outpatient setting. The US Centers for Medicare & Medicaid Services...
9.
Erickson T, Pletcher S, Soler Z, Schlosser R, Workman A, Rathi V
Otolaryngol Head Neck Surg
. 2024 Oct;
172(1):360-365.
PMID: 39413315
High prescription drug prices can financially strain patients and insurers, with substantial clinical repercussions. In recent years, direct-to-consumer (DTC) pharmacies have emerged as potentially lower-cost alternatives for patients to fill...
10.
Modernizing Medical Device Regulation: Challenges and Opportunities for the 510(k) Clearance Process
Kadakia K, Rathi V, Dhruva S, Ross J, Krumholz H
Ann Intern Med
. 2024 Oct;
177(11):1558-1565.
PMID: 39374526
Nearly all medical devices reviewed by the U.S. Food and Drug Administration (FDA) are authorized via the 510(k) clearance process. Established in 1976, this review pathway bases authorizations on the...